Researcher Services

Research Departments

Research Divisions

PUBLICATIONS

Publications powered by Harvard Catalyst Profiles

  1. Kim HB, Lee EJ, Vakili K, Stein DR, Ferguson MA, Porras D, Lock JE, Fynn-Thompson F, Fishman SJ. Mesenteric Artery Growth Improves Circulation (MAGIC) in Midaortic Syndrome. Ann Surg. 2018 Jun; 267(6):e109-e111. View abstract
  2. Warejko JK, Schueler M, Vivante A, Tan W, Daga A, Lawson JA, Braun DA, Shril S, Amann K, Somers MJG, Rodig NM, Baum MA, Daouk G, Traum AZ, Kim HB, Vakili K, Porras D, Lock J, Rivkin MJ, Chaudry G, Smoot LB, Singh MN, Smith ER, Mane SM, Lifton RP, Stein DR, Ferguson MA, Hildebrandt F. Whole Exome Sequencing Reveals a Monogenic Cause of Disease in ˜43% of 35 Families With Midaortic Syndrome. Hypertension. 2018 Apr; 71(4):691-699. View abstract
  3. Kim HB, Vakili K, Ramos-Gonzalez GJ, Stein DR, Ferguson MA, Porras D, Lock JE, Chaudry G, Alomari A, Fishman SJ. Tissue expander-stimulated lengthening of arteries for the treatment of midaortic syndrome in children. J Vasc Surg. 2018 Jun; 67(6):1664-1672. View abstract
  4. Blinder JJ, Agus MSD, Ferguson MA. The authors reply. Pediatr Crit Care Med. 2017 Dec; 18(12):1191. View abstract
  5. Warejko JK, Tan W, Daga A, Schapiro D, Lawson JA, Shril S, Lovric S, Ashraf S, Rao J, Hermle T, Jobst-Schwan T, Widmeier E, Majmundar AJ, Schneider R, Gee HY, Schmidt JM, Vivante A, van der Ven AT, Ityel H, Chen J, Sadowski CE, Kohl S, Pabst WL, Nakayama M, Somers MJG, Rodig NM, Daouk G, Baum M, Stein DR, Ferguson MA, Traum AZ, Soliman NA, Kari JA, El Desoky S, Fathy H, Zenker M, Bakkaloglu SA, Müller D, Noyan A, Ozaltin F, Cadnapaphornchai MA, Hashmi S, Hopcian J, Kopp JB, Benador N, Bockenhauer D, Bogdanovic R, Stajic N, Chernin G, Ettenger R, Fehrenbach H, Kemper M, Munarriz RL, Podracka L, Büscher R, Serdaroglu E, Tasic V, Mane S, Lifton RP, Braun DA, Hildebrandt F. Whole Exome Sequencing of Patients with Steroid-Resistant Nephrotic Syndrome. Clin J Am Soc Nephrol. 2018 Jan 06; 13(1):53-62. View abstract
  6. Daga A, Majmundar AJ, Braun DA, Gee HY, Lawson JA, Shril S, Jobst-Schwan T, Vivante A, Schapiro D, Tan W, Warejko JK, Widmeier E, Nelson CP, Fathy HM, Gucev Z, Soliman NA, Hashmi S, Halbritter J, Halty M, Kari JA, El-Desoky S, Ferguson MA, Somers MJG, Traum AZ, Stein DR, Daouk GH, Rodig NM, Katz A, Hanna C, Schwaderer AL, Sayer JA, Wassner AJ, Mane S, Lifton RP, Milosevic D, Tasic V, Baum MA, Hildebrandt F. Whole exome sequencing frequently detects a monogenic cause in early onset nephrolithiasis and nephrocalcinosis. Kidney Int. 2018 Jan; 93(1):204-213. View abstract
  7. Tan W, Lovric S, Ashraf S, Rao J, Schapiro D, Airik M, Shril S, Gee HY, Baum M, Daouk G, Ferguson MA, Rodig N, Somers MJG, Stein DR, Vivante A, Warejko JK, Widmeier E, Hildebrandt F. Analysis of 24 genes reveals a monogenic cause in 11.1% of cases with steroid-resistant nephrotic syndrome at a single center. Pediatr Nephrol. 2018 Feb; 33(2):305-314. View abstract
  8. Yoo R, Alomari AI, Shaikh R, Davis SL, Ferguson MA, Vakili K, Kim HB, Chaudry G. Catheter-Directed Thrombolysis in a Child with Bilateral Renal Artery Graft Thrombosis. J Vasc Interv Radiol. 2017 Aug; 28(8):1184-1188. View abstract
  9. Blinder JJ, Asaro LA, Wypij D, Selewski DT, Agus MSD, Gaies M, Ferguson MA. Acute Kidney Injury After Pediatric Cardiac Surgery: A Secondary Analysis of the Safe Pediatric Euglycemia After Cardiac Surgery Trial. Pediatr Crit Care Med. 2017 Jul; 18(7):638-646. View abstract
  10. Twichell SA, Rea CJ, Melvin P, Capraro AJ, Mandel JC, Ferguson MA, Nigrin DJ, Mandl KD, Graham D, Zachariah JP. The effect of an electronic health record-based tool on abnormal pediatric blood pressure recognition. Congenit Heart Dis. 2017 Jul; 12(4):484-490. View abstract
  11. Johnson PK, Ferguson MA, Zachariah JP. In-Clinic Blood Pressure Prediction of Normal Ambulatory Blood Pressure Monitoring in Pediatric Hypertension Referrals. Congenit Heart Dis. 2016 Jul; 11(4):309-14. View abstract
  12. Gee HY, Jun I, Braun DA, Lawson JA, Halbritter J, Shril S, Nelson CP, Tan W, Stein D, Wassner AJ, Ferguson MA, Gucev Z, Sayer JA, Milosevic D, Baum M, Tasic V, Lee MG, Hildebrandt F. Mutations in SLC26A1 Cause Nephrolithiasis. Am J Hum Genet. 2016 06 02; 98(6):1228-1234. View abstract
  13. Ferguson MA, Sutton RM, Karlsson M, Sjövall F, Becker LB, Berg RA, Margulies SS, Kilbaugh TJ. Increased platelet mitochondrial respiration after cardiac arrest and resuscitation as a potential peripheral biosignature of cerebral bioenergetic dysfunction. J Bioenerg Biomembr. 2016 06; 48(3):269-79. View abstract
  14. Stein DR, Ferguson MA. Evaluation and treatment of hypertensive crises in children. Integr Blood Press Control. 2016; 9:49-58. View abstract
  15. Braun DA, Lawson JA, Gee HY, Halbritter J, Shril S, Tan W, Stein D, Wassner AJ, Ferguson MA, Gucev Z, Fisher B, Spaneas L, Varner J, Sayer JA, Milosevic D, Baum M, Tasic V, Hildebrandt F. Prevalence of Monogenic Causes in Pediatric Patients with Nephrolithiasis or Nephrocalcinosis. Clin J Am Soc Nephrol. 2016 Apr 07; 11(4):664-72. View abstract
  16. Dye BR, Hill DR, Ferguson MA, Tsai YH, Nagy MS, Dyal R, Wells JM, Mayhew CN, Nattiv R, Klein OD, White ES, Deutsch GH, Spence JR. In vitro generation of human pluripotent stem cell derived lung organoids. Elife. 2015 Mar 24; 4. View abstract
  17. Ferguson MA. Commentary on "protective effect of pulmonary hypertension against right-sided tamponade in pericardial effusion". South Med J. 2015 Jan; 108(1):49-50. View abstract
  18. Sternberg JM, Gierlinski M, Biéler S, Ferguson MA, Ndung'u JM. Evaluation of the diagnostic accuracy of prototype rapid tests for human African trypanosomiasis. PLoS Negl Trop Dis. 2014 Dec; 8(12):e3373. View abstract
  19. Brand S, Norcross NR, Thompson S, Harrison JR, Smith VC, Robinson DA, Torrie LS, McElroy SP, Hallyburton I, Norval S, Scullion P, Stojanovski L, Simeons FR, van Aalten D, Frearson JA, Brenk R, Fairlamb AH, Ferguson MA, Wyatt PG, Gilbert IH, Read KD. Lead optimization of a pyrazole sulfonamide series of Trypanosoma brucei N-myristoyltransferase inhibitors: identification and evaluation of CNS penetrant compounds as potential treatments for stage 2 human African trypanosomiasis. J Med Chem. 2014 Dec 11; 57(23):9855-69. View abstract
  20. Miller MH, Walsh SV, Atrih A, Huang JT, Ferguson MA, Dillon JF. Serum proteome of nonalcoholic fatty liver disease: a multimodal approach to discovery of biomarkers of nonalcoholic steatohepatitis. J Gastroenterol Hepatol. 2014 Oct; 29(10):1839-47. View abstract
  21. Pickett CA, Villines TC, Ferguson MA, Hulten EA. Cost effectiveness of percutaneous closure versus medical therapy for cryptogenic stroke in patients with a patent foramen ovale. Am J Cardiol. 2014 Nov 15; 114(10):1584-9. View abstract
  22. Pickett CA, Villines TC, Ferguson MA, Hulten EA. Percutaneous closure versus medical therapy alone for cryptogenic stroke patients with a patent foramen ovale: meta-analysis of randomized controlled trials. Tex Heart Inst J. 2014 Aug; 41(4):357-67. View abstract
  23. Sullivan L, Fleming J, Sastry L, Mehlert A, Wall SJ, Ferguson MA. Identification of sVSG117 as an immunodiagnostic antigen and evaluation of a dual-antigen lateral flow test for the diagnosis of human African trypanosomiasis. PLoS Negl Trop Dis. 2014 Jul; 8(7):e2976. View abstract
  24. Fleming JR, Sastry L, Crozier TW, Napier GB, Sullivan L, Ferguson MA. Proteomic selection of immunodiagnostic antigens for Trypanosoma congolense. PLoS Negl Trop Dis. 2014 Jun; 8(6):e2936. View abstract
  25. Davis ML, Ferguson MA, Zachariah JP. Clinical predictors and impact of ambulatory blood pressure monitoring in pediatric hypertension referrals. J Am Soc Hypertens. 2014 Sep; 8(9):660-7. View abstract
  26. Porras D, Stein DR, Ferguson MA, Chaudry G, Alomari A, Vakili K, Fishman SJ, Lock JE, Kim HB. Midaortic syndrome: 30 years of experience with medical, endovascular and surgical management. Pediatr Nephrol. 2013 Oct; 28(10):2023-33. View abstract
  27. Ferguson MA, Flynn JT. Rational use of antihypertensive medications in children. Pediatr Nephrol. 2014 Jun; 29(6):979-88. View abstract
  28. Lahiri T, Guillet A, Diehl S, Ferguson M. High-dose ibuprofen is not associated with increased biomarkers of kidney injury in patients with cystic fibrosis. Pediatr Pulmonol. 2014 Feb; 49(2):148-53. View abstract
  29. Vakili K, Fullington NM, Turner CG, Cauley RP, Potanos KM, Lee S, Ferguson M, Lock JE, Kim HB. Aorto-mesenteric and renal allograft transplant: a novel treatment for midaortic syndrome. Am J Transplant. 2013 Apr; 13(4):1088-1092. View abstract
  30. Kim HB, Vakili K, Modi BP, Ferguson MA, Guillot AP, Potanos KM, Prabhu SP, Fishman SJ. A novel treatment for the midaortic syndrome. N Engl J Med. 2012 Dec 13; 367(24):2361-2. View abstract
  31. Taylor ML, Carmona F, Thiagarajan RR, Westgate L, Ferguson MA, del Nido PJ, Rajagopal SK. Mild postoperative acute kidney injury and outcomes after surgery for congenital heart disease. J Thorac Cardiovasc Surg. 2013 Jul; 146(1):146-52. View abstract
  32. Renella R, Stickney C, Keswani M, Mancuso T, Casavant D, Ferguson M, Narla A. Fulminant thrombotic microangiopathy in pediatrics: where diagnostic and therapeutic dilemmas meet. Am J Hematol. 2012 Aug; 87(8):816-8. View abstract
  33. Ferguson MA, Waikar SS. Established and emerging markers of kidney function. Clin Chem. 2012 Apr; 58(4):680-9. View abstract
  34. Ferguson MA, Vaidya VS, Waikar SS, Collings FB, Sunderland KE, Gioules CJ, Bonventre JV. Urinary liver-type fatty acid-binding protein predicts adverse outcomes in acute kidney injury. Kidney Int. 2010 Apr; 77(8):708-14. View abstract
  35. Vaidya VS, Waikar SS, Ferguson MA, Collings FB, Sunderland K, Gioules C, Bradwin G, Matsouaka R, Betensky RA, Curhan GC, Bonventre JV. Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. Clin Transl Sci. 2008 Dec; 1(3):200-8. View abstract
  36. Ferguson MA, Vaidya VS, Bonventre JV. Biomarkers of nephrotoxic acute kidney injury. Toxicology. 2008 Mar 20; 245(3):182-93. View abstract
  37. Vaidya VS, Ferguson MA, Bonventre JV. Biomarkers of acute kidney injury. Annu Rev Pharmacol Toxicol. 2008; 48:463-93. View abstract
  38. Murphy MT, Templeton LJ, Fleming J, Ferguson M, Peterkin M, Fraser RH. Comparison of Fy(b) status as determined serologically and genetically. Transfus Med. 1997 Jun; 7(2):135-41. View abstract